Penumbra, Inc. Scheduled to Present at Major Conference
Penumbra, Inc. (NYSE: PEN), a leader in thrombectomy technology, has announced that their management team is set to present at a significant growth conference. This event serves as a platform for the company to showcase its latest advancements and innovations in medical technology, specifically focusing on the treatment of serious conditions like ischemic stroke and venous thromboembolism.
Details of the Presentation
The presentation is scheduled to take place at the Canaccord Genuity 45th Annual Growth Conference. The company's leadership will share insights into their cutting-edge technologies and their impact on patient care. This is an anticipated appearance for an organization dedicated to improving healthcare outcomes for patients suffering from acute medical conditions.
Event Details
What is the Event?
The Canaccord Genuity 45th Annual Growth Conference is a renowned gathering that connects innovative companies with investors. During this event, Penumbra will engage with stakeholders who share an interest in advancing medical technology.
When is the Presentation Scheduled?
The presentation is set for Tuesday at 12:30 PM ET. This timing allows a wide audience to participate and understand the initiatives Penumbra is undertaking in the realm of healthcare technology.
How Can the Presentation be Accessed?
A webcast of the presentation will be available for viewing through the "Events and Presentations" section on the company's official website. Interested parties can access this resource to follow along with the discussions and insights shared by the Penumbra team.
Pioneering Innovations in Healthcare
Penumbra, Inc. stands at the forefront of innovation, focusing particularly on thrombectomy procedures that remove blood clots in critical situations. The company has developed a range of technologies, such as computer-assisted vacuum thrombectomy (CAVT), that enhance the speed, safety, and efficiency of medical procedures.
About Penumbra
As the world's leading thrombectomy company, Penumbra, Inc. is dedicated to delivering groundbreaking solutions for challenging medical conditions. Their innovative devices are designed to support healthcare providers across more than 100 countries, significantly improving patient outcomes and quality of life. Through their wide-ranging portfolio, which addresses various vascular emergencies, they aim to ensure that patients receive timely and effective treatment.
Connect with Penumbra
For those eager to learn more about their work and initiatives, Penumbra invites individuals to visit their website for updates and connect on social media platforms. Engaging with the community is vital for companies like Penumbra, as it fosters an environment of shared knowledge and support in complex medical scenarios.
Investor Relations
For any inquiries related to investor relations, please contact Penumbra, Inc. directly. Staying connected with investors is crucial for the company's ongoing success and for sharing their vision of innovative healthcare solutions.
Frequently Asked Questions
What is the focus of Penumbra's presentation at the conference?
The presentation will highlight Penumbra's innovative technologies for treating serious medical conditions, particularly in thrombectomy procedures.
When will Penumbra's management team be presenting?
The presentation is scheduled for Tuesday at 12:30 PM ET.
How can I view the presentation?
You can access the presentation via a webcast available on Penumbra's official website under the 'Investors' section.
What technologies does Penumbra focus on?
Penumbra specializes in developing advanced thrombectomy devices and techniques that improve patient outcomes in critical healthcare settings.
How can I find more information about Penumbra, Inc.?
For additional information, you can visit Penumbra's website and follow their social media channels for updates and insights.
